Assetmark Inc. Sells 2,609 Shares of Humana Inc. (NYSE:HUM)

Assetmark Inc. lessened its position in Humana Inc. (NYSE:HUM) by 17.7% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 12,114 shares of the insurance provider’s stock after selling 2,609 shares during the period. Assetmark Inc.’s holdings in Humana were worth $3,074,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of HUM. Janney Montgomery Scott LLC increased its stake in Humana by 11.6% in the third quarter. Janney Montgomery Scott LLC now owns 3,721 shares of the insurance provider’s stock valued at $1,179,000 after purchasing an additional 388 shares in the last quarter. Van ECK Associates Corp bought a new stake in Humana in the third quarter valued at approximately $424,000. Principal Financial Group Inc. increased its stake in Humana by 2.4% in the third quarter. Principal Financial Group Inc. now owns 170,636 shares of the insurance provider’s stock valued at $54,047,000 after purchasing an additional 3,961 shares in the last quarter. Atria Investments Inc increased its position in shares of Humana by 18.1% during the third quarter. Atria Investments Inc now owns 5,552 shares of the insurance provider’s stock worth $1,759,000 after acquiring an additional 851 shares in the last quarter. Finally, Sustainable Insight Capital Management LLC increased its position in shares of Humana by 15.3% during the third quarter. Sustainable Insight Capital Management LLC now owns 39,830 shares of the insurance provider’s stock worth $12,616,000 after acquiring an additional 5,300 shares in the last quarter. Institutional investors own 92.38% of the company’s stock.

Humana Stock Performance

Shares of HUM stock opened at $259.86 on Monday. The stock has a market cap of $31.35 billion, a P/E ratio of 26.12, a P/E/G ratio of 2.05 and a beta of 0.57. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76. The company has a fifty day moving average price of $271.80 and a two-hundred day moving average price of $283.10. Humana Inc. has a one year low of $213.31 and a one year high of $406.46.

Humana (NYSE:HUM) last announced its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, beating analysts’ consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. As a group, equities analysts predict that Humana Inc. will post 16.47 EPS for the current year.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be paid a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.36%. The ex-dividend date of this dividend is Friday, March 28th. Humana’s dividend payout ratio is presently 35.58%.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on HUM shares. Piper Sandler increased their price objective on shares of Humana from $270.00 to $288.00 and gave the stock a “neutral” rating in a research report on Wednesday, January 15th. Barclays increased their price objective on shares of Humana from $255.00 to $270.00 and gave the stock an “equal weight” rating in a research report on Thursday, February 13th. Cantor Fitzgerald reissued a “neutral” rating and set a $290.00 price objective on shares of Humana in a research report on Wednesday, February 12th. Morgan Stanley lowered their price objective on shares of Humana from $301.00 to $285.00 and set an “equal weight” rating for the company in a research report on Wednesday, February 12th. Finally, Royal Bank of Canada reissued an “outperform” rating and set a $283.00 price objective on shares of Humana in a research report on Wednesday, February 12th. Twenty investment analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and an average price target of $285.68.

Insider Transactions at Humana

In other news, insider Timothy S. Huval sold 3,703 shares of the firm’s stock in a transaction dated Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the sale, the insider now owns 8,181 shares in the company, valued at approximately $2,096,463.06. This trade represents a 31.16 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 0.32% of the stock is currently owned by corporate insiders.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.